FR2390161A1 - Compositions antimicrobiennes contenant des derives d'ethers d'azolyle - Google Patents

Compositions antimicrobiennes contenant des derives d'ethers d'azolyle

Info

Publication number
FR2390161A1
FR2390161A1 FR7813636A FR7813636A FR2390161A1 FR 2390161 A1 FR2390161 A1 FR 2390161A1 FR 7813636 A FR7813636 A FR 7813636A FR 7813636 A FR7813636 A FR 7813636A FR 2390161 A1 FR2390161 A1 FR 2390161A1
Authority
FR
France
Prior art keywords
compositions containing
ether derivatives
antimicrobial compositions
azolyl
azolyl ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7813636A
Other languages
English (en)
Other versions
FR2390161B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2390161A1 publication Critical patent/FR2390161A1/fr
Application granted granted Critical
Publication of FR2390161B1 publication Critical patent/FR2390161B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a trait au domaine des médicaments. Elle concerne une composition antimycosique qui renferme comme ingrédients actifs des dérivés d'éthers d'azolyle ou leurs sels ou complexes métalliques acceptables du point de vue physiologique. La composition de l'invention peut être appliquée au traitement de mycoses en médecine humaine et en médecine vétérinaire.
FR7813636A 1977-05-10 1978-05-09 Compositions antimicrobiennes contenant des derives d'ethers d'azolyle Granted FR2390161A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772720868 DE2720868A1 (de) 1977-05-10 1977-05-10 Antimikrobielle mittel

Publications (2)

Publication Number Publication Date
FR2390161A1 true FR2390161A1 (fr) 1978-12-08
FR2390161B1 FR2390161B1 (fr) 1980-07-11

Family

ID=6008463

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7813636A Granted FR2390161A1 (fr) 1977-05-10 1978-05-09 Compositions antimicrobiennes contenant des derives d'ethers d'azolyle

Country Status (7)

Country Link
US (1) US4233311A (fr)
JP (2) JPS53139730A (fr)
AU (1) AU521768B2 (fr)
BE (1) BE866832A (fr)
DE (1) DE2720868A1 (fr)
FR (1) FR2390161A1 (fr)
GB (1) GB1585940A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2925687A1 (de) * 1979-06-26 1981-01-22 Basf Ag Triazolylglykolether enthaltende mittel zur regulierung des pflanzenwachstums
DE2931756A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Antimikrobielle mittel
DE2931778A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Antimikrobielle mittel
DE2931665A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Imidazolyl-enolether, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE2931755A1 (de) * 1979-08-04 1981-02-19 Bayer Ag 1,2,4-triazolyl-enolether, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
DE3000140A1 (de) 1980-01-04 1981-07-09 Basf Ag, 6700 Ludwigshafen Fungizide azolyl-silyl-glykolether, ihre herstellung und verwendung
DE3021551A1 (de) * 1980-06-07 1981-12-24 Bayer Ag, 5090 Leverkusen 4-substituierte 1-azolyl-1-phenoxy-3,3-dimethyl-butan-2-one und -ole, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3202604A1 (de) * 1982-01-27 1983-08-04 Bayer Ag, 5090 Leverkusen Ether-derivate von substituierten 1-hydroxyalkyl-azolen, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren
DE3234624A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Fungizide mittel
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (fr) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Systeme pharma-informatique
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
SE532906C2 (sv) * 2008-09-23 2010-05-04 Scania Cv Abp Hydrolyskatalysator med större kanaltvärsnitt i den perifera delen än i den centrala delen samt sätt för hydrolys av ett urinämne
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (fr) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Compositions pour libération dermique comprenant des complexes principe actif-particule de phosphate de calcium et procédés d'utilisation associés
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2325156A1 (de) * 1973-05-18 1974-12-05 Bayer Ag Fungizide und mikrobizide mittel
DE2333355C2 (de) * 1973-06-30 1984-01-19 Bayer Ag, 5090 Leverkusen Antimikrobielle Mittel
DE2350123C2 (de) * 1973-10-05 1983-04-14 Bayer Ag, 5090 Leverkusen 1-Propyl-imidazol-Derivate und deren Salze, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
DE2350124A1 (de) * 1973-10-05 1975-04-10 Bayer Ag Antimikrobielle mittel

Also Published As

Publication number Publication date
JPS53139730A (en) 1978-12-06
JPS53139729A (en) 1978-12-06
GB1585940A (en) 1981-03-11
AU521768B2 (en) 1982-04-29
AU3580678A (en) 1979-11-08
BE866832A (fr) 1978-11-09
FR2390161B1 (fr) 1980-07-11
US4233311A (en) 1980-11-11
DE2720868A1 (de) 1978-11-23

Similar Documents

Publication Publication Date Title
FR2390161A1 (fr) Compositions antimicrobiennes contenant des derives d'ethers d'azolyle
US4607101A (en) Method of treating acne vulgaris with a composition containing carbamide peroxide
KR920019333A (ko) 치아의 표백에 사용될 수 있는 중합체 조성물 및 상기 조성물의 기타 치과적 사용방법
KR920021139A (ko) 약학 조성물
CH683237A5 (de) Eine topische, Allylamin-enthaltende, Nagellack Formulierung.
FR2411821A1 (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et 1-hydroxyoctahydrophenanthrene-9-ones et medicament les contenant
US4301145A (en) Antiseptic skin cream
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
BR9809057A (pt) Composições antitussìgenas
US3395236A (en) Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
JPH07501327A (ja) クロルヘキシジンおよびオイゲノールを含む殺菌性医薬組成物
FR2358893A1 (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
Sheskin Study with nine thalidomide derivatives in the lepra reaction
DE2504615C3 (de) Verfahren zur Herstellung eines Geles mit einem Gehalt an ß-Methason- 17-benzoat bzw. Fluocinolonacetonid und Neomycin
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
FR2357250A1 (fr) Composition antimycosique topique contenant un imidazolyl-phenoxyphenyl-pyridinyl-phenylmethane
US6365200B1 (en) Topical skin sensitizer
US5369129A (en) Preparation of topical treatment of infections caused by virus, bacteria and fungi
Botter Further experiences with miconazole nitrate, a broad‐spectrum antimycotic with antibacterial activity
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons
GB1424598A (en) Disinfectant
EP0479850A1 (fr) Preparation de traitement local d'infections provoquees par un virus, des bacteries et des champignons.

Legal Events

Date Code Title Description
ST Notification of lapse